ETOMIDATE INJECTION

The Defense Logistics Agency awarded a delivery order under contract SPE2DX25D9900 to DMS PHARMACEUTICAL GROUP INC (CAGE 1UNB0) for the supply of ETOMIDATE INJECTION, identified by NSN 6505015334392. The total contract value is $38.32, with delivery mandated by July 31, 2026, to the designated destination at Fort Bragg, North Carolina, under FOB DESTINATION terms, meaning the contractor assumes all transportation costs and risks until delivery is completed. The order specifies a strict quantity of 1.000 PG with zero tolerance for variance, and no substitutions or alternatives are permitted. Packaging and shipping must utilize traceable methods, explicitly prohibiting parcel post, and require proper marking including the manufacturer’s CAGE codes (32655, 86491), NDC numbers, and a Traceable Control Number (W8002S52741612) for accountability. Payment is to be processed through the Defense Finance and Accounting Service in Columbus, Ohio, via the Wide Area WorkFlow system in compliance with DFARS 252.232-7003. The contract is administered by Lisa Quinn, Contracting Officer, with Shairy M. Cartagena handling administrative coordination, though no separate Contracting Officer’s Representative is named. The procurement is classified under NAICS 424210 and reflects a minimal-dollar, single-line-item award under an IDIQ framework with no indication of competitive evaluation factors or socioeconomic set-asides. No formal contract clauses, statutory certifications, militarized packaging standards, or quality specifications beyond contractual conformity were detailed, and no attachments or special requirements beyond delivery, invoicing, and traceability obligations were identified.